Laval, Quebec. (February 27, 2020) — Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead
candidate selection to proof of concept, today announced that it has acquired Alliance Contract Pharma.
HARLEYSVILLE, Pa. (September 24, 2019) — Alliance Contract Pharma (ACP) announced today that the Company’s new $2 million Liquid Capsule filling line is fully operational. The new filling line significantly increases the Company’s manufacturing capacity and provides increased redundancy and flexibility for ACP clients.
Expertise, dedication, quality, cost effective and speed. In the health care industry, these values are commonly stated but not often achieved. Alliance Contract Pharma is a proven exception to the rule. Their steadfast commitment to each customer relationship is the reason drug developers engage ACP to solve problems and deliver innovative results.
The most common reason for producing sub-micron or nano-sized dispersions is to increase oral bioavailability of poorly soluble drugs. Other advantages include reduced fed/fasted variability, as well as faster onset of therapeutic action.